Overview Investment Highlights FAQ Stock Quote News Releases SEC Filings Analyst Coverage Webcasts CFMI (PPT) Presentation Standard & Poor’s Email Alerts & IR Contact
Balance Sheet
Cash
$9.5m
Working Capital
$24.1m
Total Assets
$48.1m
Long Term Debt
Nil
Net Worth
$45.6m
Shares Outstanding
12,539,662
Market Capitalization
$64.0m
Current Price*
$5.10 (3/31/2011)
Selected Income Statement Items
$mm FYE 12/31
2006
2007
2008
2009
2010
Revenues
$ 4.9
$ 10.5
$ 18.2
$ 26.7
$ 34.2
y-o-y growth
111.4%
73.8%
47.0%
28.1%
EBITDA
1.9
4.3
9.6
11.7
11.2
121.3%
126.6%
21.7%
-4.2%
EBITDA Margin
38.9%
40.7%
53.0%
43.9%
32.7%
EBIT
1.6
3.8
9.0
10.9
10.4
Margin
31.9%
36.5%
49.5%
40.9%
30.4%
Net Income
$ 1.3
$ 3.5
$ 7.3
$ 8.9
$ 8.4
26.0%
33.5%
40.4%
33.4%
24.6%
Diluted EPS
$ 0.84
$ 0.95
$ 0.75
Home | Profile | Management | Products | Investor Relations | Contact | Site Map | Privacy Policy | Disclaimer | FAQ Copyright © 2011 China Pharmaceuticals, Inc. All rights reserved. Tel: 86-29-8406-7215 OTCBB Listed CFMI